Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol

INTRODUCTION: End-stage kidney disease (ESKD) is a major public health problem affecting more than 2 million people worldwide. It is one of the most severe chronic non-communicable diseases. Haemodialysis (HD) is the most common therapeutic option but is also associated with a risk of cardiovascular...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Open
Hlavní autoři: Blankestijn, Peter J, Fischer, Kathrin I, Barth, Claudia, Cromm, Krister, Canaud, Bernard, Davenport, Andrew, Grobbee, Diederick E, Hegbrant, Jörgen, Roes, Kit C, Rose, Matthias, Strippoli, Giovanni FM, Vernooij, Robin WM, Woodward, Mark, de Wit, G Ardine, Bots, Michiel L
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2020
Témata:
Renal Medicine
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7044930/
https://ncbi.nlm.nih.gov/pubmed/32029487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-033228
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky